Ronald Harold Wilfred Cooper Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ronald Harold Wilfred Cooper.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ronald Harold Wilfred Cooper. Ronald Harold Wilfred Cooper is a President and CEO in ALBIREO PHARMA, INC. ($BIOD) and a Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and a in Generation Bio Co. ($GBIO).
Address: C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE 5TH FLOOR CAMBRIDGE 02410 MA
Companies in which Ronald Harold Wilfred Cooper is an Insider
ALBIREO PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ronald Harold Wilfred Cooper: President and CEO
Holdings: 56,460 shares
Latest Transaction: Jan 25 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Generation Bio Co.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ronald Harold Wilfred Cooper:
Holdings: 0 shares
Latest Transaction: Mar 03 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOCEA BIOSCIENCES, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ronald Harold Wilfred Cooper: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2020
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ronald Harold Wilfred Cooper
Sentiment: All, ALBO, GBIO, GNCA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | GBIO | Generation Bio Co. | Cooper Ronald Harold Wilfred | Option Exercise | A | 40.20 | 30,000 | 1,206,000 | 30,000 | ||
| Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 34.88 | 93,000 | 3,243,840 | 93,000 | |
| Jan 25 2021 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Grant | A | 0.00 | 48,700 | 0 | 56,460 | 7.8 K to 56.5 K (+627.58 %) |
| Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jan 23 2020 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 24.67 | 124,000 | 3,059,080 | 124,000 | |
| Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Cooper Ronald Harold Wilfred | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
| Jan 24 2019 | ALBO | ALBIREO PHARMA, IN ... | Cooper Ronald Harold Wilfred | President and CEO | Option Exercise | A | 24.04 | 124,000 | 2,980,960 | 124,000 |